Enbrel's label updated to include TB risk

Drugmaker Amgen has updated the U.S. prescribing information on the rheumatoid arthritis (RA) drug Enbrel. The prescribing information now contains a boxed warning to alert users to the risk of infections, including tuberculosis, in people who use tumor necrosis factor inhibitor drugs. The boxed warning also includes information about screening and monitoring Enbrel users for tuberculosis, including those who have tested negative for latent tuberculosis infection.

(BusinessWire) UPDATED 03/17/2008
Click here to read the full story
Conditions: | rheumatoid arthritis (RA) - 261 Articles Treatments: | Enbrel - 34 Articles | tumor necrosis factor - 59 Articles
Helpful?
YesNo 




Navigation

Member Picks
Three vitamin supplements reflux sufferers may need
View Full Story
Chronic pain harms the brain
View Full Story
Research your meds on the Treatments tab
View Full Story
Caffeine could spell trouble for diabetics
View Full Story